{"hands_on_practices": [{"introduction": "Effective phage therapy begins with a quantitative understanding of the battle between phage replication and bacterial growth. This exercise guides you through building a foundational mass-action model to describe these population dynamics [@problem_id:5040606]. By deriving the critical threshold for bacterial clearance, you will uncover the fundamental principle that governs whether a phage population can successfully overwhelm a bacterial infection.", "problem": "A renewed interest in bacteriophage therapy in translational medicine motivates principled dosing rules grounded in first principles of mass-action kinetics. Consider a lytic bacteriophage acting on a single susceptible bacterial population in a well-mixed compartment (e.g., a localized infection site). Let $N(t)$ denote the bacterial number density (number per milliliter) and $P(t)$ denote the free phage number density (number per milliliter). Assume:\n- In the absence of phage, bacteria grow exponentially at per-capita rate $r$ (units: $\\text{time}^{-1}$).\n- Phage adsorption to bacteria follows mass-action kinetics with adsorption rate constant $\\phi$ (units: $\\text{volume}\\cdot\\text{time}^{-1}\\cdot\\text{number}^{-1}$), producing a bacterial loss term proportional to $N(t)P(t)$.\n- Each successful adsorption event yields, after a short latent period that is neglected at the timescale of interest, a net contribution of $\\beta$ new free phage particles per event to the free phage pool (burst size $\\beta$ is dimensionless).\n- Free phage are cleared or inactivated at rate $d$ (units: $\\text{time}^{-1}$).\n\n(a) Write down the minimal mass-action dynamical system consistent with the above assumptions for $\\dot{N}(t)$ and $\\dot{P}(t)$.\n\n(b) Using this dynamical system, define the instantaneous bacterial clearance threshold as the minimal initial free phage density $P_{c}$ such that, for any given positive initial bacterial density $N(0)=N_{0}>0$, the initial net bacterial rate of change satisfies $\\dot{N}(0)<0$. Derive $P_{c}$ explicitly in terms of the parameters $r$ and $\\phi$.\n\nExpress $P_{c}$ in number per milliliter. Your final answer must be a single closed-form analytic expression; do not substitute numerical values, and no rounding is required.", "solution": "The problem requires the formulation of a mass-action kinetic model for phage-bacterium interaction and the subsequent derivation of an initiation threshold for bacterial clearance.\n\n(a) Formulation of the dynamical system.\n\nLet $N(t)$ be the number density of bacteria and $P(t)$ be the number density of free phages at time $t$. The dynamics of the bacterial population, $\\dot{N}(t) = \\frac{dN}{dt}$, are determined by two processes: growth and phage-induced lysis.\n\n1.  Bacterial Growth: In the absence of phages, the bacterial population grows exponentially. The per-capita growth rate is given as $r$. This contributes a positive term to the rate of change, proportional to the current bacterial density $N(t)$. The growth term is thus $+rN(t)$.\n\n2.  Bacterial Loss due to Phage Adsorption: Phage adsorption to bacteria is assumed to follow mass-action kinetics. The rate of interactions between phages and bacteria is proportional to the product of their densities, $N(t)P(t)$. The proportionality constant is the adsorption rate constant, $\\phi$. Each adsorption event leads to the lysis and death of the bacterium. This contributes a negative term to the rate of change. The loss term is thus $-\\phi N(t)P(t)$.\n\nCombining these terms, the differential equation for the bacterial density is:\n$$ \\dot{N}(t) = rN(t) - \\phi N(t)P(t) $$\n\nThe dynamics of the free phage population, $\\dot{P}(t) = \\frac{dP}{dt}$, are determined by phage replication from bacterial lysis and natural clearance or inactivation.\n\n1.  Phage Production: Each successful adsorption event, occurring at a rate of $\\phi N(t)P(t)$, results in a net contribution of $\\beta$ new phage particles. This means that for every interaction, the phage population increases by $\\beta$ particles. This contributes a positive term to the rate of change. The production term is thus $+\\beta \\phi N(t)P(t)$. The wording \"net contribution\" implies that the loss of the single phage particle that initiated the infection is already accounted for in the parameter $\\beta$.\n\n2.  Phage Clearance: Free phages are cleared from the system or become inactive at a per-capita rate $d$. This contributes a negative term proportional to the current phage density $P(t)$. The clearance term is thus $-dP(t)$.\n\nCombining these terms, the differential equation for the free phage density is:\n$$ \\dot{P}(t) = \\beta \\phi N(t)P(t) - dP(t) $$\n\nTherefore, the minimal mass-action dynamical system is:\n$$ \\dot{N}(t) = N(t)(r - \\phi P(t)) $$\n$$ \\dot{P}(t) = P(t)(\\beta \\phi N(t) - d) $$\n\n(b) Derivation of the instantaneous bacterial clearance threshold, $P_c$.\n\nThe instantaneous bacterial clearance threshold, $P_c$, is defined as the minimal initial free phage density, which we denote as $P(0)$, such that the initial net rate of change of the bacterial population is negative. The initial conditions are given as $N(0) = N_0$, where $N_0 > 0$.\n\nThe condition for the bacterial population to begin decreasing at time $t=0$ is:\n$$ \\dot{N}(0) < 0 $$\n\nUsing the equation for $\\dot{N}(t)$ derived in part (a), we evaluate it at $t=0$:\n$$ \\dot{N}(0) = rN(0) - \\phi N(0)P(0) $$\n\nSubstituting the initial condition $N(0) = N_0$:\n$$ \\dot{N}(0) = rN_0 - \\phi N_0 P(0) $$\n\nNow, we apply the inequality for initial bacterial clearance:\n$$ rN_0 - \\phi N_0 P(0) < 0 $$\n\nWe need to solve this inequality for $P(0)$.\n$$ rN_0 < \\phi N_0 P(0) $$\n\nSince the problem states $N_0 > 0$, and the adsorption rate constant $\\phi$ must be positive for any interaction to occur, we can divide both sides of the inequality by the positive quantity $\\phi N_0$ without changing the direction of the inequality sign.\n$$ \\frac{rN_0}{\\phi N_0} < P(0) $$\n\nThis simplifies to:\n$$ P(0) > \\frac{r}{\\phi} $$\n\nThis inequality specifies the condition on the initial phage density $P(0)$ for the bacterial population to begin to decline. The threshold $P_c$ is the minimal value that serves as the boundary for this condition. The set of values for $P(0)$ satisfying the condition is the interval $(\\frac{r}{\\phi}, \\infty)$. The infimum, or greatest lower bound, of this set is $\\frac{r}{\\phi}$. Therefore, the bacterial clearance threshold $P_c$ is given by this value.\n\n$$ P_c = \\frac{r}{\\phi} $$\n\nThe units of this expression are consistent. The per-capita bacterial growth rate $r$ has units of $\\text{time}^{-1}$, and the adsorption rate constant $\\phi$ has units of $\\text{volume}\\cdot\\text{time}^{-1}\\cdot\\text{number}^{-1}$. Thus, the units of $P_c$ are:\n$$ \\frac{[\\text{time}^{-1}]}{[\\text{volume}\\cdot\\text{time}^{-1}\\cdot\\text{number}^{-1}]} = \\frac{\\text{number}}{\\text{volume}} $$\nThis corresponds to a number density, as required for $P_c$. The derived expression is in terms of the parameters $r$ and $\\phi$, as requested. It is notably independent of the initial bacterial density $N_0$.", "answer": "$$\\boxed{\\frac{r}{\\phi}}$$", "id": "5040606"}, {"introduction": "A single phage is often not enough, as bacterial populations are notoriously diverse and can rapidly evolve resistance. This practice explores the primary strategy to overcome this challenge: the phage cocktail [@problem_id:5040605]. You will apply principles of probability to quantify how combining phages that target different bacterial receptors can dramatically increase the likelihood of therapeutic success.", "problem": "A translational medicine team is designing a bacteriophage therapy cocktail for carbapenem-resistant Klebsiella pneumoniae. The goal is to maximize the fraction of the pathogen population that is susceptible to at least one of the phages in the cocktail. Each phage in the cocktail binds a distinct cell-surface receptor: capsule K-antigen, lipopolysaccharide (LPS) core, outer membrane porin OmpK35, Type 1 fimbriae, and an O-acetylated exopolysaccharide. Single-cell phenotyping and multi-omics profiling in the intended clinical milieu indicate that the receptor phenotypes are orthogonal in their regulation and expression, and thus can be modeled as independent at the single-cell level. The measured prevalence of each receptor phenotype in the bacterial population is $p_1 = 0.62$, $p_2 = 0.41$, $p_3 = 0.27$, $p_4 = 0.33$, and $p_5 = 0.15$. The multiplicity of infection (MOI) is maintained sufficiently high so that a bacterium expressing any one of the targeted receptors is effectively killed by at least one cognate phage, and there is no cross-interference among phages.\n\nStarting from the foundational rules of probability (definitions of event independence, union, and complement), derive an expression for the expected coverage of the pathogen population by the cocktail, defined as the probability that a randomly chosen bacterium expresses at least one of the targeted receptors. Then compute its numerical value using the given receptor prevalences. Express the final expected coverage as a decimal fraction, and round your answer to four significant figures.", "solution": "Let $E_i$ be the event that a randomly chosen bacterium expresses receptor $i$, for $i \\in \\{1, 2, 3, 4, 5\\}$. The problem provides the prevalences of these receptor phenotypes, which correspond to the probabilities of these events: $P(E_1) = p_1 = 0.62$, $P(E_2) = p_2 = 0.41$, $P(E_3) = p_3 = 0.27$, $P(E_4) = p_4 = 0.33$, and $P(E_5) = p_5 = 0.15$.\n\nThe \"expected coverage\" is the probability that a bacterium expresses at least one of the receptors. This is the probability of the union of the events, $P(E_1 \\cup E_2 \\cup E_3 \\cup E_4 \\cup E_5)$. A direct calculation using the principle of inclusion-exclusion is cumbersome. A more efficient approach is to use the complement rule.\n\nLet $R$ be the complement event, where a bacterium expresses *none* of the five receptors (i.e., it is resistant to the entire cocktail). The probability of coverage is then $1 - P(R)$. The event $R$ is the intersection of the complement events $E'_i$: $R = E'_1 \\cap E'_2 \\cap E'_3 \\cap E'_4 \\cap E'_5$.\n\nAs the events $E_i$ are independent, their complements $E'_i$ are also independent. Therefore, the probability of their intersection is the product of their individual probabilities:\n$$P(R) = \\prod_{i=1}^{5} P(E'_i) = \\prod_{i=1}^{5} (1 - p_i)$$\nThe general expression for coverage is therefore:\n$$\\text{Coverage} = 1 - \\prod_{i=1}^{5} (1 - p_i)$$\n\nNow, we compute the numerical value. First, we calculate the probabilities of non-expression, $(1 - p_i)$:\n$1 - p_1 = 1 - 0.62 = 0.38$\n$1 - p_2 = 1 - 0.41 = 0.59$\n$1 - p_3 = 1 - 0.27 = 0.73$\n$1 - p_4 = 1 - 0.33 = 0.67$\n$1 - p_5 = 1 - 0.15 = 0.85$\n\nNext, we calculate their product, which is the probability $P(R)$ that a bacterium is resistant to the entire cocktail:\n$$P(R) = 0.38 \\times 0.59 \\times 0.73 \\times 0.67 \\times 0.85 = 0.093207787$$\n\nFinally, the expected coverage is:\n$$\\text{Coverage} = 1 - P(R) = 1 - 0.093207787 = 0.906792213$$\n\nThe problem requires the answer to be rounded to four significant figures. The final answer is $0.9068$.", "answer": "$$\\boxed{0.9068}$$", "id": "5040605"}, {"introduction": "Translating a phage therapy strategy into a clinical protocol requires precise dosage calculations that account for the patient's unique physiology. This hands-on problem focuses on determining the necessary intravenous dose to achieve a therapeutic phage concentration in the bloodstream, integrating the concepts of Multiplicity of Infection (MOI) with real-world pharmacokinetic parameters [@problem_id:5040558]. Mastering this calculation is essential for moving from a promising therapy to a practical treatment.", "problem": "An interdisciplinary translational medicine team is preparing an intravenous administration of a bacteriophage cocktail for a patient with acute bloodstream infection. The immediate therapeutic goal is to achieve, at $t=0^{+}$ after infusion and instantaneous mixing, a post-clearance phage concentration $C^{*}$ in the central circulating compartment sufficient to exceed a required phage-to-bacterium ratio for rapid lysis. The following are established from first principles and measurements:\n\n- The definition of Multiplicity of Infection (MOI) states that the ratio of phage to bacteria within a unit volume is the multiplicity-of-infection. Denote the required multiplicity-of-infection for rapid lysis in whole blood by $\\text{MOI}_{\\mathrm{eff}}$.\n- The patientâ€™s circulating bacterial load is estimated at $B = 4.0 \\times 10^{6}$ colony-forming units per milliliter (CFU/mL).\n- The minimum effective multiplicity-of-infection determined from in vitro whole-blood kill curves and adjusted for in vivo conditions is $\\text{MOI}_{\\mathrm{eff}} = 12$.\n- The central compartment (accessible plasma volume for phage at $t=0^{+}$) is $V = 3.0~\\mathrm{L}$.\n- Due to preexisting innate and adaptive factors (e.g., complement and phagocytes), an immediate fraction $f = 0.55$ of infused particles is cleared prior to establishing the well-mixed post-infusion concentration.\n\nAssume a single-compartment, instantaneous mixing model at $t=0^{+}$, and use conservation of mass together with the definition of multiplicity-of-infection to derive the expression for the total infused dose $D$ (in plaque-forming units) that ensures the post-clearance concentration equals the target $C^{*}$ implied by the required multiplicity-of-infection. Then compute $D$ using the numerical values provided. Express the dose in plaque-forming units (PFU) and round your answer to three significant figures.", "solution": "The problem requires the derivation of an expression for the total infused bacteriophage dose, $D$, and the calculation of its numerical value. This will be accomplished by following the principles of conservation of mass and the definition of multiplicity of infection (MOI) within a single-compartment model.\n\nFirst, we must determine the target phage concentration, $C^{*}$, required in the central compartment immediately after infusion and clearance. The problem defines the effective multiplicity-of-infection, $\\text{MOI}_{\\mathrm{eff}}$, as the ratio of the phage concentration to the bacterial concentration. The bacterial concentration is given as $B$. Thus, we have:\n$$\n\\text{MOI}_{\\mathrm{eff}} = \\frac{C^{*}}{B}\n$$\nSolving for the target phage concentration $C^{*}$ yields:\n$$\nC^{*} = \\text{MOI}_{\\mathrm{eff}} \\cdot B\n$$\nHere, $C^{*}$ will have units of plaque-forming units per unit volume (PFU/mL), as $B$ is in colony-forming units per unit volume (CFU/mL) and $\\text{MOI}_{\\mathrm{eff}}$ is a dimensionless ratio.\n\nSecond, we calculate the total number of effective phage particles, $N_{\\text{eff}}$, needed within the central compartment volume, $V$, to achieve the target concentration $C^{*}$. This is given by the product of the concentration and the volume:\n$$\nN_{\\text{eff}} = C^{*} \\cdot V\n$$\nSubstituting the expression for $C^{*}$ from the previous step, we get:\n$$\nN_{\\text{eff}} = (\\text{MOI}_{\\mathrm{eff}} \\cdot B) \\cdot V\n$$\n\nThird, we must account for the initial, rapid clearance of a fraction of the infused dose. The problem states that a fraction $f$ of the total infused dose $D$ is cleared immediately. Therefore, the fraction of the dose that remains to establish the therapeutic concentration is $(1-f)$. The number of effective phage particles, $N_{\\text{eff}}$, is this remaining fraction of the total dose $D$:\n$$\nN_{\\text{eff}} = D \\cdot (1 - f)\n$$\n\nNow, we can derive the symbolic expression for $D$ by equating the two expressions for $N_{\\text{eff}}$:\n$$\nD \\cdot (1 - f) = \\text{MOI}_{\\mathrm{eff}} \\cdot B \\cdot V\n$$\nSolving for the total infused dose $D$, we obtain the final analytical expression:\n$$\nD = \\frac{\\text{MOI}_{\\mathrm{eff}} \\cdot B \\cdot V}{1 - f}\n$$\n\nNext, we compute the numerical value for $D$ using the provided data:\n- $\\text{MOI}_{\\mathrm{eff}} = 12$ (dimensionless)\n- $B = 4.0 \\times 10^{6}~\\text{CFU/mL}$\n- $V = 3.0~\\mathrm{L}$\n- $f = 0.55$ (dimensionless)\n\nIt is critical to ensure consistency of units. The volume $V$ is given in liters (L) while the bacterial load $B$ is in CFU per milliliter (mL). We must convert the volume to milliliters:\n$$\nV = 3.0~\\mathrm{L} \\times \\frac{1000~\\mathrm{mL}}{1~\\mathrm{L}} = 3.0 \\times 10^{3}~\\mathrm{mL}\n$$\nNow, we substitute these values into the derived expression for $D$:\n$$\nD = \\frac{12 \\cdot (4.0 \\times 10^{6}~\\text{mL}^{-1}) \\cdot (3.0 \\times 10^{3}~\\text{mL})}{1 - 0.55}\n$$\nFirst, we calculate the numerator, which represents the total number of effective phages, $N_{\\text{eff}}$, required in the volume $V$:\n$$\nN_{\\text{eff}} = 12 \\cdot (4.0 \\times 10^{6}) \\cdot (3.0 \\times 10^{3}) = 144 \\times 10^{9} = 1.44 \\times 10^{11}~\\text{PFU}\n$$\nNext, we calculate the denominator, which represents the fraction of the dose remaining after immediate clearance:\n$$\n1-f = 1 - 0.55 = 0.45\n$$\nFinally, we compute $D$:\n$$\nD = \\frac{1.44 \\times 10^{11}}{0.45} = 3.2 \\times 10^{11}~\\text{PFU}\n$$\nThe problem requires the answer to be rounded to three significant figures. The calculated value $3.2 \\times 10^{11}$ can be expressed as $3.20 \\times 10^{11}$ to reflect this precision.", "answer": "$$\\boxed{3.20 \\times 10^{11}}$$", "id": "5040558"}]}